A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound

• Автори: Iris C. Salaroglio (Автор), Denitsa Stefanova (Автор), Ricardo G. Teixeira (Автор), Nuno F.B. Oliveira (Автор), Amer Ahmed (Автор), Fabio Fusi (Автор), Virginia Tzankova (Автор), Yordan Yordanov (Автор), Miguel Machuqueiro (Автор), Simona Saponara (Автор), Andreia Valente (Автор), Chiara Riganti (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2024-10-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

The therapeutic approach to many solid tumors, including non-small cell lung cancer (NSCLC), is mainly based on the use of platinum-containing anticancer agents and is often characterized by acquired or intrinsic resistance to the drug. Therefore, the search for safer and more effective drugs is sti...